問卷

TPIDB > Search Result

Search Result

篩選

List

2449Cases

2016-10-01 - 2025-12-31

Others

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2025-01-01 - 2031-06-30

Phase III

Active
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of Vorasidenib (S095032/AG-881) in Asian Participants with Residual or Recurrent Grade 2 Glioma with an IDH1 or IDH2 Mutation
  • Condition/Disease

    Residual or Recurrent Grade 2 IDH Mutant Glioma

  • Test Drug

    Vorasidenib

Participate Sites
2Sites

Recruiting2Sites

2021-11-01 - 2026-12-31

Phase I

Active
A Dose-Escalating Phase I Study to Determine the Safety, and Maximum Tolerated Dose/ Maximum Feasible Dose of Autologous ex vivo Expanded and Activated NK cell, Magicell-NK, Infusion for Colon Cancer post Resection
  • Condition/Disease

    Colon Cancer Stage I/IIa

  • Test Drug

    Magicell-NK

Participate Sites
1Sites

Recruiting1Sites

2017-01-01 - 2028-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2012-03-01 - 2018-01-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Terminated12Sites

2022-12-01 - 2024-07-08

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2022-12-01 - 2025-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2014-02-01 - 2014-10-31

Phase I

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2009-12-01 - 2014-01-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

-

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites